Tesla Inc (NASDAQ:TSLA) Q4 2021 Earnings Call dated Jan. 26, 2022. Corporate Participants: Martin Viecha -- Senior Director, Investor Relations Elon Musk -- Chief Executive Officer
Tesla Inc (TSLA) Q4 2021 Earnings Call Transcript
Categories
Latest News
ServiceNow, Inc. (NOW) Q4 2021 Earnings Call Transcript
ServiceNow, Inc. (NYSE: NOW) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Darren Yip -- Vice President, Investor Relations Bill McDermott -- President and
Intel Corporation (INTC) Q4 2021 Earnings Call Transcript
Intel Corporation (NASDAQ: INTC) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Tony Balow -- Vice President, Investor Relations Patrick Gelsinger -- Chief Executive
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2021 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations
Lam Research Corporation (LRCX) Q4 2021 Earnings Call Transcript
Lam Research Corporation (NASDAQ: LRCX) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Tina Correia -- Corporate Vice President, Corporate Finance and
Earnings: Tesla (TSLA) Q4 2021 results beat estimates amid record deliveries
Tesla Inc. (NASDAQ: TSLA) on Wednesday said its fourth-quarter earnings rose sharply and topped expectations. Driving the bottom-line growth, revenues rose 65%
Microsoft (MSFT) becomes a compelling buy after strong earnings, Activision deal
Microsoft Corp. (NASDAQ: MSFT) is one of the most innovative technology companies, constantly transforming the business to align with the rapidly changing
Corning Incorporated (GLW) Q4 2021 Earnings Call Transcript
Corning Incorporated (NYSE: GLW) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Ann H.S. Nicholson -- Vice President of Investor Relations Wendell
AT&T Inc. (T) Q4 2021 Earnings Call Transcript
AT&T Inc. (NYSE: T) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Amir Rozwadowski -- Senior Vice President, Finance and Investor Relations
INTERVIEW: Evelo’s SINTAX medicines could address a broad range of inflammatory disorders
Credit:DavidBGray on iStock Evelo Biosciences (Nasdaq:EVLO) is a clinical-stage biotechnology company that is focused on a newly uncovered area of central human
Nasdaq, Inc. (NDAQ) Q4 2021 Earnings Call Transcript
Nasdaq, Inc. (NASDAQ: NDAQ) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Ed Ditmire -- Senior Vice President of Investor Relations Adena